BIOA · Company research
BioAge Labs, Inc. Common Stock (BIOA): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
15records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| BioArctic (OM:BIOA B) Stock May Be Fully Priced On Sales Growth Hopes - Yahoo Finance | BioArctic (OM:BIOA B) Stock May Be Fully Priced On Sales Growth Hopes Yahoo Finance | View source ↗ | Yahoo Finance | Oct 9, 2026 | neutral | 0 | 0.6 |
| (BIOA) and the Role of Price-Sensitive Allocations - Stock Traders Daily | (BIOA) and the Role of Price-Sensitive Allocations Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 7, 2026 | neutral | 0 | 0.6 |
| BIOA Oct 2026 25.000 call (BIOA261016C00025000) Stock Price, News, Quote & History - Yahoo! Finance Canada | BIOA Oct 2026 25.000 call (BIOA261016C00025000) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 4, 2026 | neutral | 0 | 0.6 |
| BioAge Labs (NasdaqGS:BIOA) Stock Forecast & Analyst Predictions - Simply Wall Street | BioAge Labs (NasdaqGS:BIOA) Stock Forecast & Analyst Predictions Simply Wall Street | View source ↗ | Simply Wall Street | Sep 14, 2026 | neutral | 0 | 0.6 |
| A daily pill for diabetic eye disease enters a Phase 2 trial - Stock Titan | A daily pill for diabetic eye disease enters a Phase 2 trial Stock Titan | View source ↗ | Stock Titan | Sep 8, 2026 | neutral | 0 | 0.6 |
| BioAge Labs posts partial recovery after deep selloff, rises 19% (BIOA:NASDAQ) - Seeking Alpha | BioAge Labs posts partial recovery after deep selloff, rises 19% (BIOA:NASDAQ) Seeking Alpha | View source ↗ | Seeking Alpha | Aug 3, 2026 | neutral | 0 | 0.6 |
| Market Movers | Winners: FWAC, REPL, MGRX | Losers: KPTI, BIOA, MBRX - Trefis | Market Movers | Winners: FWAC, REPL, MGRX | Losers: KPTI, BIOA, MBRX Trefis | View source ↗ | Trefis | Aug 3, 2026 | neutral | 0 | 0.6 |
| BIOA Stock Pulls Back Sharply After Recent Spike - StocksToTrade | BIOA Stock Pulls Back Sharply After Recent Spike StocksToTrade | View source ↗ | StocksToTrade | Aug 2, 2026 | neutral | 0 | 0.6 |
| BIOA, GLUE Stocks Clock Worst Day In Years— What’s The NVO Connection? - Stocktwits | BIOA, GLUE Stocks Clock Worst Day In Years— What’s The NVO Connection? Stocktwits | View source ↗ | Stocktwits | Jul 31, 2026 | neutral | 0 | 0.6 |
| Monte Rosa, BioAge plunge as Novo’s setback casts a shadow over pipeline - Seeking Alpha | Monte Rosa, BioAge plunge as Novo’s setback casts a shadow over pipeline Seeking Alpha | View source ↗ | Seeking Alpha | Jul 31, 2026 | neutral | 0 | 0.6 |
| Why Is BioAge Labs Stock Sinking Friday? - Benzinga | Why Is BioAge Labs Stock Sinking Friday? Benzinga | View source ↗ | Benzinga | Jul 31, 2026 | neutral | 0 | 0.6 |
| $BIOA stock is down 60% today. Here's what we see in our data. - Quiver Quantitative | $BIOA stock is down 60% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Jul 31, 2026 | neutral | 0 | 0.6 |
| Insider Sale: Principal Accounting Officer of $BIOA Sells 20,216 Shares | BIOA Stock News - Quiver Quantitative | Insider Sale: Principal Accounting Officer of $BIOA Sells 20,216 Shares | BIOA Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | Jul 1, 2026 | neutral | 0 | 0.6 |
| BIOA Forecast — Price Target — Prediction for 2027 - TradingView | BIOA Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| BioAge Labs, Inc. Common Stock (BIOA) Stock Price: Oct 6 Close $6.29 - Gotrade | BioAge Labs, Inc. Common Stock (BIOA) Stock Price: Oct 6 Close $6.29 Gotrade | View source ↗ | Gotrade | Jan 13, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.